No Label Ventures

11x is pioneering a transformative approach to revenue generation by creating autonomous AI workers that handle routine tasks, allowing human sales teams to focus on building relationships and innovating. Rather than selling software, 11x delivers complete outcomes through digital workers that operate 24/7 across various channels, fundamentally changing how businesses approach sales.

Callyope is a Clinical AI platform designed to enhance mental health care by providing clinicians with tools for efficient patient monitoring, clinical documentation, and decision support, all powered by specialized AI models tailored for psychiatry.

Guided Energy builds real-time AI agents that coordinate freight logistics, aiming to modernize the transportation industry by automating manual coordination and legacy systems.

Intropy is an AI platform designed for the parts industry, helping businesses optimize their operations through data-driven insights and automation.

Melotech is revolutionizing media and entertainment by creating art through technology, focusing on music, films, and community engagement.

Mesh Security is a cybersecurity firm that transforms security data into real-time adaptive defense, promoting Zero Trust in cloud security.

Mizou provides an AI-powered platform for creating realistic training simulations that help learners practice and improve their skills in various scenarios, such as customer service and negotiations, with instant feedback and progress tracking.

Pangea Bio is a clinical stage biotech company focused on developing transformative medicines for neurological and mental health disorders, utilizing AI-powered drug discovery to activate the TrkB receptor pathway.

PostX is a logistics platform that offers 100% emission-free routes by leveraging intelligent planning, virtual sortation, and an asset-light model to optimize middle-mile logistics.

Spore Bio is a company focused on reinventing microbiology testing through ultra-fast, AI-based technology that integrates deep learning and biophotonics for rapid microbial detection across various industries.

Exclusively backs startups with at least one immigrant founder, leveraging immigrant leadership and Semyon Dukach's probabilistic, MIT Blackjack Team-derived approach to evaluate founders and venture risk. The fund's leadership are themselves immigrants who position immigrant status as a competitive advantage and signal of grit.

Felicis explicitly defines founders as their customer rather than LPs and has publicly committed to always vote with founders in board matters. The firm created a 1% Founder Development Pledge providing non-dilutive capital for founders personal development like coaching and therapy. Felicis systematically optimizes for revenue efficiency and backs geo-agnostic teams outside Silicon Valley, focusing on reinvention of large existing markets with 10x better products and frontier solutions in areas like longevity and engineered foods.